Articles

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Mayo Clinic School of Medicine, Rochester, MN, USA
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
Vol. 104 No. 10 (2019): October, 2019 https://doi.org/10.3324/haematol.2018.211110